N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling

Cancer Letters

Volumn 354, Issue 1, 2014, Pages 33-42

  Kim, Myung Jin ^a   Lim, Jihyun ^a   Yang, Young ^a   Lee, Myeong Sok ^a   Lim, Jong Seok ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Breast cancer; EMT; NDRG2; Snail; STAT3

Indexed keywords

CUCURBITACIN; MYC PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; NDRG2 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; STAT3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUCIFERASE ASSAY; NDRG2 GENE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING; CELL MOTION; EMT; GENE EXPRESSION REGULATION; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; NDRG2; PROMOTER REGION; SIGNAL TRANSDUCTION; SNAIL; TUMOR CELL LINE; TUMOR INVASION;

GASTROPODA;

BREAST CANCER; EMT; NDRG2; SNAIL; STAT3;

CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 84909997554     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.06.023     Document Type: Article

References (52)

1. Popescu N.C., Zimonjic D.B. Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy. Am. J. Med. Genet 2002, 115:142-149.
2. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
3. Lerebours F., Lidereau R. Molecular alterations in sporadic breast cancer. Crit. Rev. Oncol. Hematol 2002, 44:121-141.
4. Oh S.S., Kim D., Kim D.H., Chang H.H., Sohn K.C., Kim K.H., et al. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-beta production. Carcinogenesis 2012, 33:1882-1888.
5. Melotte V., Qu X., Ongenaert M., van Criekinge W., de Bruine A.P., Baldwin H.S., et al. The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J. 2010, 24:4153-4166.
6. Hu X.L., Liu X.P., Lin S.X., Deng Y.C., Liu N., Li X., et al. NDRG2 expression and mutation in human liver and pancreatic cancers. World J. Gastroenterol 2004, 10:3518-3521.
7. Hu X.L., Liu X.P., Deng Y.C., Lin S.X., Wu L., Zhang J., et al. Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues. Cell Tissue Res 2006, 325:67-76.
8. Yao L., Zhang J., Liu X. NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:625-635.
9. Lorentzen A., Lewinsky R.H., Bornholdt J., Vogel L.K., Mitchelmore C. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer. BMC Cancer 2011, 11:14-21.
10. Ma J., Liu W., Yan X., Wang Q., Zhao Q., Xue Y., et al. Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells. PLoS ONE 2012, 7:e32368.
11. Choi S.C., Kim K.D., Kim J.T., Kim J.W., Yoon D.Y., Choe Y.K., et al. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett 2003, 553:413-418.
12. Kim Y.J., Yoon S.Y., Kim J.T., Choi S.C., Lim J.S., Kim J.H., et al. NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int. J. Cancer 2009, 124:7-15.
13. Shon S.K., Kim A., Kim J.Y., Kim K.I., Yang Y., Lim J.S. Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem. Biophys. Res. Commun 2009, 385:198-203.
14. Kim A., Kim M.J., Yang Y., Kim J.W., Yeom Y.I., Lim J.S. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis 2009, 30:927-936.
15. Garg M. Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer. World J. Stem Cells 2013, 5:188-195.
16. Chakrabarti R., Hwang J., Andres Blanco M., Wei Y., Lukacisin M., Romano R.A., et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat. Cell Biol 2012, 14:1212-1222.
17. Park J., Schwarzbauer J.E. Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition. Oncogene 2014, 33:1649-1657.
18. Lee M.Y., Shen M.R. Epithelial-mesenchymal transition in cervical carcinoma. Am. J. Transl. Res 2012, 4:1-13.
19. Dhasarathy A., Kajita M., Wade P.A. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol. Endocrinol 2007, 21:2907-2918.
20. Moody S.E., Perez D., Pan T.C., Sarkisian C.J., Portocarrero C.P., Sterner C.J., et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8:197-209.
21. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol 2013, 15:677-687.
22. Zhang W., Feng M., Zheng G., Chen Y., Wang X., Pen B., et al. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem. Biophys. Res. Commun 2012, 417:679-685.
23. Scherbakov A.M., Stefanova L.B., Sorokin D.V., Semina S.E., Berstein L.M., Krasil'nikov M.A. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack. Exp. Cell Res 2013, 319:3150-3159.
24. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
25. Haricharan S., Li Y. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol. Cell. Endocrinol 2014, 382:560-569.
26. Costantino L., Barlocco D. STAT 3 as a target for cancer drug discovery. Curr. Med. Chem 2008, 15:834-843.
27. Hsieh F.C., Cheng G., Lin J. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem. Biophys. Res. Commun 2005, 335:292-299.
28. Park Y., Shon S.K., Kim A., Kim K.I., Yang Y., Cho D.H., et al. SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem. Biophys. Res. Commun 2007, 363:361-367.
29. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007, 67:9066-9076.
30. Xiong H., Hong J., Du W., Lin Y.W., Ren L.L., Wang Y.C., et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J. Biol. Chem 2012, 287:5819-5832.
31. Hogstrand C., Kille P., Ackland M.L., Hiscox S., Taylor K.M. A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3). Biochem. J. 2013, 455:229-237.
32. Balanis N., Wendt M.K., Schiemann B.J., Wang Z., Schiemann W.P., Carlin C.R. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J. Biol. Chem 2013, 288:17954-17967.
33. Guo L., Chen C., Shi M., Wang F., Chen X., Diao D., et al. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 2013, 32:5272-5282.
34. Yu H., Jove R. The STATs of cancer - new molecular targets come of age. Nat. Rev. Cancer 2004, 4:97-105.
35. Turkson J., Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000, 19:6613-6626.
36. Al Zaid Siddiquee K., Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 2008, 18:254-267.
37. Kamran M.Z., Patil P., Gude R.P. Role of STAT3 in cancer metastasis and translational advances. Biomed. Res. Int 2013, 2013:421821.
38. Carpenter R.L., Lo H.W. STAT3 target genes relevant to human cancers. Cancers 2014, 6:897-925.
39. Hou Z., Peng H., Ayyanathan K., Yan K.P., Langer E.M., Longmore G.D., et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol. Cell. Biol 2008, 28:3198-3207.
40. Li R., Yu C., Jiang F., Gao L., Li J., Wang Y., et al. Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo. PLoS ONE 2013, 8:e76689.
41. Ma J.J., Kong L.M., Liao C.G., Jiang X., Wang Y., Bao T.Y. Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion. Med. Oncol 2012, 29:3306-3313.
42. Lusis E.A., Watson M.A., Chicoine M.R., Lyman M., Roerig P., Reifenberger G., et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 2005, 65:7121-7126.
43. Liu N., Wang L., Liu X., Yang Q., Zhang J., Zhang W., et al. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem. Biophys. Res. Commun 2007, 358:164-169.
44. Gao L., Wu G.J., Liu X.W., Zhang R., Yu L., Zhang G., et al. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene. Cancer Lett 2011, 310:94-100.
45. Zheng J., Li Y., Yang J., Liu Q., Shi M., Zhang R., et al. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer 2011, 11:251-259.
46. Kim Y.J., Kang H.B., Yim H.S., Kim J.H., Kim J.W. NDRG2 positively regulates E-cadherin expression and prolongs overall survival in colon cancer patients. Oncol. Rep 2013, 30:1890-1898.
47. Hix L.M., Karavitis J., Khan M.W., Shi Y.H., Khazaie K., Zhang M. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells. J. Biol. Chem 2013, 288:11676-11688.
48. Barash I. Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease. Carcinogenesis 2012, 33:2320-2325.
49. Britschgi A., Andraos R., Brinkhaus H., Klebba I., Romanet V., Muller U., et al. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell 2012, 22:796-811.
50. Yadav A., Kumar B., Datta J., Teknos T.N., Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol. Cancer Res 2011, 9:1658-1667.
51. Gnemmi V., Bouillez A., Gaudelot K., Hemon B., Ringot B., Pottier N., et al. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/beta-catenin pathway and interaction with SNAIL promoter. Cancer Lett 2014, 346:225-236.
52. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol 2007, 293:L525-L534.